Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate Cancer

Abstract

Active surveillance has been relatively uncommon in Medicare beneficiaries with localized prostate cancer. Its use relative to watchful waiting varies based on patient demographics, tumor severity and geographic location.